We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
Cap. Flow
+$4.56B
Cap. Flow %
5.05%
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344

Sector Composition

Rank Sector Weight
1 Financials 11.61%
2 Technology 10.97%
3 Healthcare 10.51%
4 Consumer Discretionary 7.19%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRG
1626
Seritage Growth Properties
SRG
$136M
$4.55M 0.01%
91,317
+29,109
+47% +$1.46M
EMBJ
1627
Embraer S.A. ADS
EMBJ
$12.2B
$4.54M 0.01%
209,193
+115,456
+123% +$2.59M
COWN
1628
DELISTED
Cowen Inc. Class A Common Stock
COWN
$4.54M 0.01%
383,617
-39,737
-9% -$541K
IYR icon
1629
CALL
iShares US Real Estate ETF
IYR
$4.66B
$4.53M 0.01%
+55,000
New +$4.31M
KANG
1630
DELISTED
iKang Healthcare Group, Inc.
KANG
$4.52M 0.01%
246,690
+146,626
+147% +$2.95M
DWRE
1631
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
$4.52M 0.01%
60,300
-160,259
-73% -$8.66M
WBS icon
1632
Webster Financial
WBS
$12.5B
$4.51M 0.01%
132,979
+65,627
+97% +$2.39M
X
1633
DELISTED
US Steel
X
$4.51M 0.01%
267,708
-50,711
-16% -$852K
RYAM icon
1634
Rayonier Advanced Materials
RYAM
$604M
$4.5M 0.01%
331,459
-52,328
-14% -$641K
BAK icon
1635
Braskem
BAK
$928M
$4.5M 0.01%
379,877
-92,417
-20% -$1.15M
DF
1636
DELISTED
Dean Foods Company
DF
$4.49M 0.01%
247,919
+164,546
+197% +$2.92M
HHH icon
1637
Howard Hughes
HHH
$3.81B
$4.48M 0.01%
41,079
+12,241
+42% +$1.26M
CXW icon
1638
CoreCivic
CXW
$2.96B
$4.46M ﹤0.01%
127,350
+35,760
+39% +$1.17M
DOX icon
1639
Amdocs
DOX
$5.92B
$4.46M ﹤0.01%
77,289
+10,828
+16% +$621K
AKS
1640
DELISTED
AK Steel Holding Corp
AKS
$4.45M ﹤0.01%
955,730
+556,303
+139% +$2.44M
SFUN
1641
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$4.45M ﹤0.01%
17,689
+10,137
+134% +$2.8M
CMPR icon
1642
Cimpress
CMPR
$2.39B
$4.45M ﹤0.01%
48,062
+24,471
+104% +$2.3M
SAIC icon
1643
Saic
SAIC
$4.95B
$4.44M ﹤0.01%
76,167
+5,101
+7% +$277K
FCN icon
1644
FTI Consulting
FCN
$4.4B
$4.44M ﹤0.01%
109,088
+60,137
+123% +$2.38M
SBRA icon
1645
Sabra Healthcare REIT
SBRA
$5.34B
$4.42M ﹤0.01%
214,163
+49,903
+30% +$1.04M
MATV icon
1646
Mativ Holdings
MATV
$481M
$4.42M ﹤0.01%
125,170
+14,940
+14% +$504K
SDY icon
1647
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$4.41M ﹤0.01%
52,603
+10,262
+24% +$834K
BHC icon
1648
PUT
Bausch Health
BHC
$2.58B
$4.41M ﹤0.01%
+218,900
New +$6.2M
MLNX
1649
DELISTED
Mellanox Technologies, Ltd.
MLNX
$4.41M ﹤0.01%
91,889
+23,142
+34% +$1.1M
PRTA icon
1650
Prothena Corp
PRTA
$425M
$4.4M ﹤0.01%
125,809
+1,779
+1% +$77.5K

Similar funds

Credit Suisse's Q2 2016 Portfolio in Review

As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.

  • Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
  • Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
  • Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
  • Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
  • Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
  • Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.